药物对比
Vildagliptin vs Dulaglutide
Vildagliptin是一种口服DPP-4抑制剂，通过延长肠促胰素激素的作用来刺激葡萄糖依赖性胰岛素分泌；而Dulaglutide是一种注射用GLP-1受体激动剂，通过模拟GLP-1来调节血糖。比较两者的作用机制、副作用以及对2型糖尿病的适用性。
此页面暂无可用的对比维度。
临床背景
Patients with type 2 diabetes seeking to compare oral DPP-4 inhibitors like Vildagliptin with injectable GLP-1 agonists like Dulaglutide.
结论
The better option between Vildagliptin and Dulaglutide depends on the patient's preference for oral versus injectable medication and their specific health needs.
全部药物对比